Correlation between morphological and functional retinal impairment in multiple sclerosis patients.

PubWeight™: 2.27‹?› | Rank: Top 2%

🔗 View Article (PMID 10509645)

Published in Invest Ophthalmol Vis Sci on October 01, 1999

Authors

V Parisi1, G Manni, M Spadaro, G Colacino, R Restuccia, S Marchi, M G Bucci, F Pierelli

Author Affiliations

1: Cattedra di Clinica Oculistica, Università di Roma Tor Vergata, Italy. vparisi@tin.it

Articles citing this

Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis. Ann Neurol (2010) 2.96

Ocular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease duration. Brain (2010) 2.61

Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis. Brain (2011) 2.21

Optical coherence tomography: a window into the mechanisms of multiple sclerosis. Nat Clin Pract Neurol (2008) 2.20

Active MS is associated with accelerated retinal ganglion cell/inner plexiform layer thinning. Neurology (2013) 2.06

Optical coherence tomography helps differentiate neuromyelitis optica and MS optic neuropathies. Neurology (2009) 1.78

Optical coherence tomography in multiple sclerosis: thickness of the retinal nerve fiber layer as a potential measure of axonal loss and brain atrophy. J Neurol (2008) 1.75

Inflammatory demyelination induces axonal injury and retinal ganglion cell apoptosis in experimental optic neuritis. Exp Eye Res (2008) 1.63

Optical coherence tomography (OCT): imaging the visual pathway as a model for neurodegeneration. Neurotherapeutics (2011) 1.57

Oral resveratrol reduces neuronal damage in a model of multiple sclerosis. J Neuroophthalmol (2010) 1.54

Correlation between retinal morphological and functional findings and clinical severity in Parkinson's disease. Doc Ophthalmol (2007) 1.46

Optical coherence tomography analysis of axonal loss in band atrophy of the optic nerve. Br J Ophthalmol (2004) 1.31

Neuromyelitis optica and multiple sclerosis: Seeing differences through optical coherence tomography. Mult Scler (2015) 1.30

Assessing structure and function of the afferent visual pathway in multiple sclerosis and associated optic neuritis. J Neurol (2009) 1.29

Vision in multiple sclerosis: the story, structure-function correlations, and models for neuroprotection. J Neuroophthalmol (2011) 1.25

The relationship between visual field and retinal nerve fiber layer measurements in patients with multiple sclerosis. Invest Ophthalmol Vis Sci (2007) 1.25

In vivo evaluation of retinal neurodegeneration in patients with multiple sclerosis. PLoS One (2012) 1.24

A preliminary longitudinal study of the retinal nerve fiber layer in progressive multiple sclerosis. J Neurol (2010) 1.20

Retinal axonal loss begins early in the course of multiple sclerosis and is similar between progressive phenotypes. PLoS One (2012) 1.16

Multifocal VEP and OCT in optic neuritis: a topographical study of the structure-function relationship. Doc Ophthalmol (2008) 1.12

Optic neuritis and retinal ganglion cell loss in a chronic murine model of multiple sclerosis. Front Neurol (2011) 1.10

The impact of utilizing different optical coherence tomography devices for clinical purposes and in multiple sclerosis trials. PLoS One (2011) 1.09

Vision and vision-related outcome measures in multiple sclerosis. Brain (2014) 1.08

Metabolic changes in the visual cortex are linked to retinal nerve fiber layer thinning in multiple sclerosis. PLoS One (2011) 1.06

Visual evoked potentials in patients with Graves' ophthalmopathy complicated by ocular hypertension and suspect glaucoma or dysthyroid optic neuropathy. Doc Ophthalmol (2003) 1.03

Resveratrol neuroprotection in a chronic mouse model of multiple sclerosis. Front Neurol (2012) 1.03

Retinal nerve fiber layer thickness in subgroups of multiple sclerosis, measured by optical coherence tomography and scanning laser polarimetry. J Neurol (2010) 0.98

Optical coherence tomography in multiple sclerosis and neuromyelitis optica: an update. Mult Scler Int (2011) 0.97

Retinal nerve changes in patients with tremor dominant and akinetic rigid Parkinson's disease. Neurol Sci (2012) 0.97

Evaluating the use of optical coherence tomography in optic neuritis. Mult Scler Int (2011) 0.96

Optical coherence tomography measures axonal loss in multiple sclerosis independently of optic neuritis. J Neurol (2007) 0.96

OCT: New perspectives in neuro-ophthalmology. Saudi J Ophthalmol (2014) 0.95

The photopic negative response of the flash electroretinogram in multiple sclerosis. Invest Ophthalmol Vis Sci (2012) 0.95

Comparison of multifocal visual evoked potential, standard automated perimetry and optical coherence tomography in assessing visual pathway in multiple sclerosis patients. Mult Scler (2010) 0.91

Optical Coherence Tomography in Alzheimer's Disease: A Meta-Analysis. PLoS One (2015) 0.89

Retinal nerve fiber layer evaluation in multiple sclerosis with spectral domain optical coherence tomography. Clin Ophthalmol (2010) 0.88

Clinically isolated syndromes suggestive of multiple sclerosis: an optical coherence tomography study. PLoS One (2012) 0.87

Low contrast visual acuity testing is associated with cognitive performance in multiple sclerosis: a cross-sectional pilot study. BMC Neurol (2013) 0.87

Optical coherence tomography as a potential readout in clinical trials. Ther Adv Neurol Disord (2010) 0.86

Retinal nerve fiber layer thickness changes in Parkinson disease: a meta-analysis. PLoS One (2014) 0.85

How strong is the relationship between glaucoma, the retinal nerve fibre layer, and neurodegenerative diseases such as Alzheimer's disease and multiple sclerosis? Eye (Lond) (2015) 0.84

Independent patterns of damage to retinocortical pathways in multiple sclerosis without a previous episode of optic neuritis. J Neurol (2011) 0.83

Optical coherence tomography versus visual evoked potentials in detecting subclinical visual impairment in multiple sclerosis. J Med Life (2015) 0.82

Outcome measures in relapsing-remitting multiple sclerosis: capturing disability and disease progression in clinical trials. Mult Scler Int (2014) 0.81

New imaging techniques in the diagnosis of multiple sclerosis. Expert Opin Med Diagn (2008) 0.81

Retinal nerve fibre layer loss in hereditary spastic paraplegias is restricted to complex phenotypes. BMC Neurol (2012) 0.80

Visual abnormalities associated with enhanced optic nerve myelination. Brain Res (2010) 0.80

Measurement of retinal nerve fiber layer thickness in optic atrophy eyes of patients with optic neuritis using optical coherence tomography. Graefes Arch Clin Exp Ophthalmol (2010) 0.80

Comparison of optical coherence tomography and scanning laser polarimetry measurements in patients with multiple sclerosis. Optom Vis Sci (2010) 0.80

Translational research in neurology and neuroscience 2010: multiple sclerosis. Arch Neurol (2010) 0.79

Imaging as an Outcome Measure in Multiple Sclerosis. Neurotherapeutics (2016) 0.79

Visual dysfunction and its correlation with retinal changes in patients with Parkinson's disease: an observational cross-sectional study. BMJ Open (2016) 0.79

Benign Multiple Sclerosis is Associated with Reduced Thinning of the Retinal Nerve Fiber and Ganglion Cell Layers in Non-Optic-Neuritis Eyes. J Clin Neurol (2015) 0.79

Effects of vitamin D on retinal nerve fiber layer in vitamin D deficient patients with optic neuritis: Preliminary findings of a randomized, placebo-controlled trial. J Res Med Sci (2015) 0.78

Outer retinal changes following acute optic neuritis. Mult Scler (2015) 0.78

Optical coherence tomography: clinical applications in medical practice. Oman Med J (2013) 0.78

Pattern electroretinograms for the detection of neural loss in patients with permanent temporal visual field defect from chiasmal compression. Doc Ophthalmol (2008) 0.78

Correlation between multifocal pattern electroretinography and Fourier-domain OCT in eyes with temporal hemianopia from chiasmal compression. Graefes Arch Clin Exp Ophthalmol (2012) 0.78

Utility of coronal contrast-enhanced fat-suppressed FLAIR in the evaluation of optic neuropathy and atrophy. Eur J Radiol Open (2017) 0.77

Retinal nerve fiber layer thickness analysis in suspected malingerers with optic disc temporal pallor. Indian J Ophthalmol (2009) 0.77

Optical coherence tomography (OCT) in optic neuritis and multiple sclerosis. Rev Neurol (Paris) (2010) 0.77

Decreased retinal sensitivity and loss of retinal nerve fibers in multiple system atrophy. Graefes Arch Clin Exp Ophthalmol (2012) 0.77

The correlation between rat retinal nerve fiber layer thickness around optic disc by using optical coherence tomography and histological measurements. Int J Ophthalmol (2013) 0.77

The optic nerve head in acquired optic neuropathies. Nat Rev Neurol (2010) 0.76

Sex-specific differences in retinal nerve fiber layer thinning after acute optic neuritis. Neurology (2012) 0.76

Pattern electroretinogram in neuromyelitis optica and multiple sclerosis with or without optic neuritis and its correlation with FD-OCT and perimetry. Doc Ophthalmol (2013) 0.75

Intranasal Delivery of A Novel Amnion Cell Secretome Prevents Neuronal Damage and Preserves Function In A Mouse Multiple Sclerosis Model. Sci Rep (2017) 0.75

Retinal microvascular network alterations: potential biomarkers of cerebrovascular and neural diseases. Am J Physiol Heart Circ Physiol (2016) 0.75

Modeling the Chronic Loss of Optic Nerve Axons and the Effects on the Retinal Nerve Fiber Layer Structure in Primary Disorder of Myelin. Invest Ophthalmol Vis Sci (2016) 0.75

Association between retinal nerve fiber layer thickness and magnetic resonance imaging findings and intelligence in patients with multiple sclerosis. Adv Biomed Res (2015) 0.75

Relationship between Structural and Functional Assessment of the Visual System in Mildly Disabled Relapsing-Remitting Multiple Sclerosis Patients. Neuroophthalmology (2014) 0.75

Retinal ganglion cell and axonal loss in optic neuritis: risk factors and visual functions. Eye (Lond) (2016) 0.75

Exploring the Association between Retinal Nerve Fiber Layer Thickness and Initial Magnetic Resonance Imaging Findings in Patients with Acute Optic Neuritis. Mult Scler Int (2011) 0.75

Outcome Measures in Clinical Trials for Multiple Sclerosis. CNS Drugs (2017) 0.75

Validity of low-contrast letter acuity as a visual performance outcome measure for multiple sclerosis. Mult Scler (2017) 0.75

Longitudinal time-domain optic coherence study of retinal nerve fiber layer in IFNβ-treated and untreated multiple sclerosis patients. Exp Ther Med (2016) 0.75

Anatomical and functional retinal changes in multiple sclerosis. Eye (Lond) (2015) 0.75

Visual Evoked Potential and Magnetic Resonance Imaging are More Effective Markers of Multiple Sclerosis Progression than Laser Polarimetry with Variable Corneal Compensation. Front Hum Neurosci (2014) 0.75

Optical Coherence Tomography as a Biomarker for Diagnosis, Progression, and Prognosis of Neurodegenerative Diseases. J Ophthalmol (2016) 0.75

Evaluation of changes in retinal nerve fiber layer thickness and visual functions in cases of optic neuritis and multiple sclerosis. Indian J Ophthalmol (2013) 0.75

Analysis of multiple sclerosis patients with electrophysiological and structural tests. Int Ophthalmol (2016) 0.75

Short-term effects of vision trainer rehabilitation in patients affected by anisometropic amblyopia: electrofunctional evaluation. Doc Ophthalmol (2014) 0.75

Articles by these authors

Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease. Gut (2005) 3.31

Role of faecal calprotectin as non-invasive marker of intestinal inflammation. Dig Liver Dis (2003) 2.79

Reflux pattern and role of impedance-pH variables in predicting PPI response in patients with suspected GERD-related chronic cough. Aliment Pharmacol Ther (2014) 2.27

Reduced habituation of trigeminal reflexes in patients with episodic cluster headache during cluster period. Cephalalgia (2008) 2.18

Ocular symptoms and signs with preserved and preservative-free glaucoma medications. Eur J Ophthalmol (2007) 2.04

Vernal keratoconjunctivitis revisited: a case series of 195 patients with long-term followup. Ophthalmology (2000) 1.68

Quality of life in patients with Charcot-Marie-Tooth disease. Neurology (2005) 1.66

Mitochondrial DNA haplogroups influence the therapeutic response to riboflavin in migraineurs. Neurology (2009) 1.65

Intrahepatic metastatic nodules of hepatocellular carcinoma detected at lipiodol-CT: imaging-pathologic correlation. Abdom Imaging (1997) 1.63

The general practitioner's approach to irritable bowel syndrome: from intention to practice. Dig Liver Dis (2005) 1.62

Double pylorus: report of two cases and review of the literature. Ital J Gastroenterol (1992) 1.60

Morphological and functional retinal impairment in Alzheimer's disease patients. Clin Neurophysiol (2001) 1.59

Efficacy of the fixed combinations of bimatoprost or latanoprost plus timolol in patients uncontrolled with prostaglandin monotherapy: a multicenter, randomized, investigator-masked, clinical study. Eur J Ophthalmol (2009) 1.59

Spectroscopic characterization of mineralogy and its diversity across Vesta. Science (2012) 1.57

The gene for autosomal dominant spinocerebellar ataxia (SCA1) maps telomeric to the HLA complex and is closely linked to the D6S89 locus in three large kindreds. Am J Hum Genet (1991) 1.53

Serum gamma-glutamyl-transpeptidase isoforms in alcoholic liver disease. Alcohol Alcohol (1997) 1.46

Early-onset progressive ataxia associated with the first CACNA1A mutation identified within the I-II loop. J Neurol Sci (2007) 1.44

Sensitisation of spinal cord pain processing in medication overuse headache involves supraspinal pain control. Cephalalgia (2010) 1.43

Mitochondrial myopathy, parkinsonism, and multiple mtDNA deletions in a Sephardic Jewish family. Neurology (2001) 1.43

VREPAR projects: the use of virtual environments in psycho-neuro-physiological assessment and rehabilitation. Cyberpsychol Behav (1999) 1.41

Acetazolamide acts on neuromuscular transmission abnormalities found in some migraineurs. Cephalalgia (2003) 1.41

Asymptomatic live systemic embolization observed on transesophageal echocardiography. Am Heart J (1993) 1.39

Is the cerebral cortex hyperexcitable or hyperresponsive in migraine? Cephalalgia (2007) 1.32

Novel SACS mutations in autosomal recessive spastic ataxia of Charlevoix-Saguenay type. Neurology (2004) 1.26

High prevalence of TT virus viremia in italian patients, regardless of age, clinical diagnosis, and previous interferon treatment. J Infect Dis (1999) 1.25

Vesta's shape and morphology. Science (2012) 1.23

Distinctive space weathering on Vesta from regolith mixing processes. Nature (2012) 1.23

Pitted terrain on Vesta and implications for the presence of volatiles. Science (2012) 1.20

Episodic ataxia type 2 (EA2) and spinocerebellar ataxia type 6 (SCA6) due to CAG repeat expansion in the CACNA1A gene on chromosome 19p. Hum Mol Genet (1997) 1.20

Identification of PTEN at the ER and MAMs and its regulation of Ca(2+) signaling and apoptosis in a protein phosphatase-dependent manner. Cell Death Differ (2013) 1.19

Familial basilar migraine associated with a new mutation in the ATP1A2 gene. Neurology (2005) 1.19

Topical lomefloxacin 0.3% twice daily versus tobramycin 0.3% in acute bacterial conjunctivitis: A multicenter double-blind phase III study. Ophthalmologica (1999) 1.16

TT virus (TTV) loads associated with different peripheral blood cell types and evidence for TTV replication in activated mononuclear cells. J Med Virol (2001) 1.16

Riluzole in cerebellar ataxia: a randomized, double-blind, placebo-controlled pilot trial. Neurology (2010) 1.15

Ataxia with oculomotor apraxia type 2: a clinical, pathologic, and genetic study. Neurology (2006) 1.15

Esophageal baseline impedance levels in patients with pathophysiological characteristics of functional heartburn. Neurogastroenterol Motil (2014) 1.14

Effect of trinucleotide repeat length and parental sex on phenotypic variation in spinocerebellar ataxia I. Am J Hum Genet (1994) 1.13

Long-term results of percutaneous ethanol injection therapy for hepatocellular carcinoma in cirrhosis: a European experience. Eur Radiol (1997) 1.11

A simple method for estimating conduction velocity of the spinothalamic tract in healthy humans. Clin Neurophysiol (2000) 1.09

Allergen dose response and late symptoms in a human model of ocular allergy. J Allergy Clin Immunol (1990) 1.08

Differences in hepatitis C virus quasispecies composition between liver, peripheral blood mononuclear cells and plasma. J Gen Virol (1997) 1.08

Flash and pattern electroretinograms during and after acute intraocular pressure elevation in cats. Invest Ophthalmol Vis Sci (1988) 1.07

Lack of habituation causes high intensity dependence of auditory evoked cortical potentials in migraine. Brain (2003) 1.06

Dynamics of persistent TT virus infection, as determined in patients treated with alpha interferon for concomitant hepatitis C virus infection. J Virol (2001) 1.06

Wolfram's syndrome: a clinical, diagnostic, and interpretative contribution. Diabetes Care (1986) 1.06

Complete loss of P/Q calcium channel activity caused by a CACNA1A missense mutation carried by patients with episodic ataxia type 2. Am J Hum Genet (2001) 1.05

Interictal abnormalities of gamma band activity in visual evoked responses in migraine: an indication of thalamocortical dysrhythmia? Cephalalgia (2007) 1.03

Correlation between optical coherence tomography, pattern electroretinogram, and visual evoked potentials in open-angle glaucoma patients. Ophthalmology (2001) 1.03

Molecular and clinical examination of an Italian DEFECT11 family. Eur J Hum Genet (1999) 1.01

Nerve growth factor (NGF) reduces and NGF antibody exacerbates retinal damage induced in rabbit by experimental ocular hypertension. Graefes Arch Clin Exp Ophthalmol (1997) 1.00

TT virus levels in the plasma of infected individuals with different hepatic and extrahepatic pathology. J Med Virol (2001) 1.00

Analgesic effect of topical diclofenac versus betamethasone after posterior segment surgery. Retina (1995) 0.99

Images of asteroid 21 Lutetia: a remnant planetesimal from the early Solar System. Science (2011) 0.99

High-performance liquid chromatographic separation and mass spectrometric identification of propafenone, 5-hydroxypropafenone and N-depropylpropafenone. J Chromatogr (1988) 0.98

Antiepileptic effects of a calcium antagonist (nimodipine) on cefazolin-induced epileptogenic foci in rabbits. Epilepsia (1986) 0.98

Serial changes in pulmonary functions in children hospitalized with cystic fibrosis. Am Rev Respir Dis (1982) 0.97

The gene for spinal cerebellar ataxia 1 (SCA1) is flanked by two closely linked highly polymorphic microsatellite loci. Hum Mol Genet (1993) 0.97

The effect of increased intraocular pressure on pulsatile ocular blood flow in low tension glaucoma. Surv Ophthalmol (1994) 0.96

Visual function correlates with nerve fiber layer thickness in eyes affected by ocular hypertension. Invest Ophthalmol Vis Sci (1999) 0.95

[Isolation of Yershinia enterocolitica in Mytilus galloprovincialis Lamk]. Boll Soc Ital Biol Sper (1968) 0.95

Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they? Neurogastroenterol Motil (2013) 0.94

Visual evoked potentials after photostress in patients with primary open-angle glaucoma and ocular hypertension. Invest Ophthalmol Vis Sci (1992) 0.94

Cytidine-5'-diphosphocholine (citicoline) improves retinal and cortical responses in patients with glaucoma. Ophthalmology (1999) 0.93

A new POLG1 mutation with peo and severe axonal and demyelinating sensory-motor neuropathy. J Neurol (2006) 0.92

The trinucleotide repeat expansion on chromosome 6p (SCA1) in autosomal dominant cerebellar ataxias. Brain (1994) 0.91

Myelinated retinal fibers in autosomal recessive spastic ataxia of Charlevoix-Saguenay. Eur J Neurol (2011) 0.91

Distribution of propafenone and its active metabolite, 5-hydroxypropafenone, in human tissues. Am Heart J (1987) 0.90

The role of Humphrey Matrix testing in the early diagnosis of retinopathy in type 1 diabetes. Br J Ophthalmol (2008) 0.89

Dynamic changes in thalamic microstructure of migraine without aura patients: a diffusion tensor magnetic resonance imaging study. Eur J Neurol (2013) 0.89

Visual alterations in de novo Parkinson's disease: pattern electroretinogram latencies are more delayed and more reversible by levodopa than are visual evoked potentials. Neurology (1995) 0.88

Hepatitis C virus chronic infection as a common cause of mixed cryoglobulinaemia and autoimmune liver disease. J Intern Med (1994) 0.88

Color Doppler assessment of normal ocular blood flow. J Ultrasound Med (1993) 0.88

Divergent evolution of hepatitis C virus in liver and peripheral blood mononuclear cells of infected patients. J Med Virol (1999) 0.87

Conjunctival hyperresponsiveness to ocular histamine challenge in patients with vernal conjunctivitis. J Allergy Clin Immunol (1992) 0.87

Infantile autosomal dominant distal myopathy. Acta Neurol Scand (1995) 0.87

Crural amyotrophy associated with a parietal lesion: a case report. Acta Neurol Belg (1995) 0.87

Cardiac tamponade as first manifestation of acute lymphoblastic leukemia in a patient with echographic evidence of mediastinal lymph nodal enlargement. Am Heart J (1985) 0.87

Early visual function impairment in CADASIL. Neurology (2003) 0.87

Gastric mucosal distribution and clinical efficacy of azithromycin in patients with Helicobacter pylori related gastritis. J Antimicrob Chemother (1998) 0.87

Electrophysiological study (VEP, BAEP) in HIV-1 seropositive patients with and without AIDS. Acta Neurol Belg (1993) 0.86

Do sex and hormonal status influence choroidal circulation? Br J Ophthalmol (2000) 0.86

The wolframin His611Arg polymorphism influences medication overuse headache. Neurosci Lett (2007) 0.85

Heat stress disorders and headache: a case of new daily persistent headache secondary to heat stroke. J Neurol Neurosurg Psychiatry (2008) 0.85

[Severe cardiomyopathy in a woman with intermediate beta-thalassemia. Regression of cardiac failure with desferrioxamine]. G Ital Cardiol (1985) 0.85

Electrophysiological assessment of visual function in newly-diagnosed IDDM patients. Diabetologia (1995) 0.85

Cutaneous afferents mediating the cutaneous silent period in the upper limbs: evidences for a role of low-threshold sensory fibres. Clin Neurophysiol (2001) 0.85

Electrophysiological assessment of visual function in IDDM patients. Electroencephalogr Clin Neurophysiol (1997) 0.84